PerkinElmer to Distribute Axxam's GPCR Screening Platform; Firms to Create Joint R&D Program | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer said today it will distribute to drug companies worldwide a luminescent cell-based assay made by Italian company Axxam.
The companies also agreed to create a joint R&D program to develop Photina GPCR and ion-channel lines to profile compounds and in high-throughput screening studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.